ODI Pharma is a manufacturer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are executed through wholesale distributors and pharmacies. The products are used in the treatment of multiple sclerosis, chronic pain and in chemotherapy. Business operations are mainly located in the European market, with the head office in Stockholm.

Quotes for ODI Pharma AB

Right Now

+/-
-0.3
%
-5,46%
Latest
5.19
High
5.37
Low
5.07
Volume
2 180
Turnover (SEK)
11 209
Value (MSEK)
79,0

Board

CEO

  • Derek Simmross

Chairman Of The Board

  • Volker Wiederrich

Board

  • Derek Simmross
  • Gösta Lidén
  • Karina Kilinski

Videos

Largest Owners

Name Capital % Votes % Date
Volker Wiederrich 41,10 41,10 2020-03-31
Derek Simmross 41,06 41,06 2020-03-31
Esk Invest AS 0,95 0,95 2020-03-31
Nordnet Pensionsförsäkring 0,87 0,87 2020-03-31
Niclas Kappelin 0,72 0,72 2020-03-31
Avanza Pension 0,49 0,49 2020-03-31
Sebastian Clausin 0,44 0,44 2020-03-31
Ghodratollah Taheri-Shemirani 0,36 0,36 2020-03-31
Kyösti Antero Tuuli 0,33 0,33 2020-03-31
Ardeshir Vafa 0,29 0,29 2020-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Upcoming reports

  • 2020-08-27 Bokslutskommuniké 2020